{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:22:03Z","timestamp":1793330523330,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","award":["DJCLS 08 R_2023"],"award-info":[{"award-number":["DJCLS 08 R_2023"]}],"id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","award":["DJCLS 01 R_2023"],"award-info":[{"award-number":["DJCLS 01 R_2023"]}],"id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2023.084.1"],"award-info":[{"award-number":["2023.084.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004875","name":"Massachusetts Department of Fish and Game","doi-asserted-by":"publisher","award":["PF1028\/1-1"],"award-info":[{"award-number":["PF1028\/1-1"]}],"id":[{"id":"10.13039\/100004875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["853988"],"award-info":[{"award-number":["853988"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41591-025-03499-9","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:14:24Z","timestamp":1740132864000},"page":"1145-1153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody"],"prefix":"10.1038","volume":"31","author":[{"given":"Till","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2805-5973","authenticated-orcid":false,"given":"Maximilian","family":"Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Klepzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5458-3788","authenticated-orcid":false,"given":"Florian","family":"Gro\u00dfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4014-6030","authenticated-orcid":false,"given":"David","family":"Fandrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6483-8062","authenticated-orcid":false,"given":"Nhu-Nguyen","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kreuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Katharina","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kuschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"Meinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7625-5139","authenticated-orcid":false,"given":"Eva","family":"Heger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1375-2386","authenticated-orcid":false,"given":"Viola","family":"Schweinsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natali","family":"Pflug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1863-3239","authenticated-orcid":false,"given":"Uwe","family":"Platzbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-4455","authenticated-orcid":false,"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Holtick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"K\u00f6hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Scheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-4872","authenticated-orcid":false,"given":"Kristin","family":"Reiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Herling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3588-6376","authenticated-orcid":false,"given":"Tim","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"3499_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1056\/NEJMoa2024850","volume":"384","author":"NC Munshi","year":"2021","unstructured":"Munshi, N. C. et al. Idecabtagene vicleucel in relapsed and refractory multiple myeloma. N. Engl. J. Med. 384, 705\u2013716 (2021).","journal-title":"N. Engl. J. Med."},{"key":"3499_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJMoa2213614","volume":"388","author":"P Rodriguez-Otero","year":"2023","unstructured":"Rodriguez-Otero, P. et al. Ide-cel or standard regimens in relapsed and refractory multiple myeloma. N. Engl. J. Med. 388, 1002\u20131014 (2023).","journal-title":"N. Engl. J. Med."},{"key":"3499_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa2303379","volume":"389","author":"J San-Miguel","year":"2023","unstructured":"San-Miguel, J. et al. Cilta-cel or standard care in lenalidomide-refractory multiple myeloma. N. Engl. J. Med. 389, 335\u2013347 (2023).","journal-title":"N. Engl. J. Med."},{"key":"3499_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41375-020-0734-z","volume":"34","author":"N Shah","year":"2020","unstructured":"Shah, N., Chari, A., Scott, E., Mezzi, K. & Usmani, S. Z. B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches. Leukemia 34, 985\u20131005 (2020).","journal-title":"Leukemia"},{"key":"3499_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3322\/caac.21771","volume":"73","author":"RH Parikh","year":"2023","unstructured":"Parikh, R. H. & Lonial, S. Chimeric antigen receptor T-cell therapy in multiple myeloma: a comprehensive review of current data and implications for clinical practice. CA Cancer J. Clin. 73, 275\u2013285 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"3499_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","volume":"22","author":"EC Morris","year":"2022","unstructured":"Morris, E. C., Neelapu, S. S., Giavridis, T. & Sadelain, M. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat. Rev. Immunol. 22, 85\u201396 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"3499_CR7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1056\/NEJMoa2401361","volume":"390","author":"MP Hamilton","year":"2024","unstructured":"Hamilton, M. P. et al. Risk of second tumors and T-cell lymphoma after CAR T-cell therapy. N. Engl. J. Med. 390, 2047\u20132060 (2024).","journal-title":"N. Engl. J. Med."},{"key":"3499_CR8","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1182\/blood.2024024166","volume":"143","author":"M Elsallab","year":"2024","unstructured":"Elsallab, M. et al. Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System. Blood 143, 2099\u20132105 (2024).","journal-title":"Blood"},{"key":"3499_CR9","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1056\/NEJMoa2402730","volume":"391","author":"G Kobbe","year":"2024","unstructured":"Kobbe, G. et al. Aggressive lymphoma after CD19 CAR T-cell therapy. N. Engl. J. Med. 391, 1217\u20131226 (2024).","journal-title":"N. Engl. J. Med."},{"key":"3499_CR10","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa2401530","volume":"390","author":"M Ozdemirli","year":"2024","unstructured":"Ozdemirli, M. et al. Indolent CD4+ CAR T-cell lymphoma after cilta-cel CAR T-cell therapy. N. Engl. J. Med. 390, 2074\u20132082 (2024).","journal-title":"N. Engl. J. Med."},{"key":"3499_CR11","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41591-024-02826-w","volume":"30","author":"G Ghilardi","year":"2024","unstructured":"Ghilardi, G. et al. T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nat. Med. 30, 984\u2013989 (2024).","journal-title":"Nat. Med."},{"key":"3499_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41591-023-02767-w","volume":"30","author":"BL Levine","year":"2024","unstructured":"Levine, B. L. et al. Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nat. Med. 30, 338\u2013341 (2024).","journal-title":"Nat. Med."},{"key":"3499_CR13","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1056\/NEJMoa2204591","volume":"387","author":"A Chari","year":"2022","unstructured":"Chari, A. et al. Talquetamab, a T-cell-redirecting GPRC5D bispecific antibody for multiple myeloma. N. Engl. J. Med. 387, 2232\u20132244 (2022).","journal-title":"N. Engl. J. Med."},{"key":"3499_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1200\/EDBK_200689","volume":"38","author":"A Moignet","year":"2018","unstructured":"Moignet, A. & Lamy, T. Latest advances in the diagnosis and treatment of large granular lymphocytic leukemia. Am. Soc. Clin. Oncol. Educ. Book 38, 616\u2013625 (2018).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"3499_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4049\/immunohorizons.2200062","volume":"7","author":"EM Muhowski","year":"2023","unstructured":"Muhowski, E. M. & Rogers, L. M. Dual TCR-expressing T cells in cancer: how single-cell technologies enable new investigation. Immunohorizons 7, 299\u2013306 (2023).","journal-title":"Immunohorizons"},{"key":"3499_CR16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1182\/blood.V106.11.708.708","volume":"106","author":"A Wiestner","year":"2005","unstructured":"Wiestner, A. et al. Differential gene expression in CLL cells from bone marrow and peripheral blood suggests a role of bone marrow stroma in leukemic cell proliferation. Blood 106, 708 (2005).","journal-title":"Blood"},{"key":"3499_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1136\/jcp.2005.031161","volume":"59","author":"E Sakhinia","year":"2006","unstructured":"Sakhinia, E. et al. Comparison of gene-expression profiles in parallel bone marrow and peripheral blood samples in acute myeloid leukaemia by real-time polymerase chain reaction. J. Clin. Pathol. 59, 1059\u20131065 (2006).","journal-title":"J. Clin. Pathol."},{"key":"3499_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29173-z","volume":"13","author":"J Huuhtanen","year":"2022","unstructured":"Huuhtanen, J. et al. Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia. Nat. Commun. 13, 1981 (2022).","journal-title":"Nat. Commun."},{"key":"3499_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-019-0716-7","volume":"12","author":"S de Mel","year":"2019","unstructured":"de Mel, S., Hue, S. S.-S., Jeyasekharan, A. D., Chng, W.-J. & Ng, S.-B. Molecular pathogenic pathways in extranodal NK\/T cell lymphoma. J. Hematol. Oncol. 12, 33 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"3499_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"3499_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r34","volume":"15","author":"S Hoffmann","year":"2014","unstructured":"Hoffmann, S. et al. A multi-split mapping algorithm for circular RNA, splicing, trans-splicing and fusion detection. Genome Biol.15, R34 (2014).","journal-title":"Genome Biol."},{"key":"3499_CR22","doi-asserted-by":"publisher","first-page":"8150","DOI":"10.1073\/pnas.0501643102","volume":"102","author":"L Liu","year":"2005","unstructured":"Liu, L., McBride, K. M. & Reich, N. C. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-\u03b13. Proc. Natl Acad. Sci. USA 102, 8150\u20138155 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3499_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101416","volume":"5","author":"Y-H Huang","year":"2024","unstructured":"Huang, Y.-H. et al. Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes. Cell Rep. Med. 5, 101416 (2024).","journal-title":"Cell Rep. Med."},{"key":"3499_CR24","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood.2021013164","volume":"139","author":"H Cheon","year":"2022","unstructured":"Cheon, H. et al. Genomic landscape of TCR\u03b1\u03b2 and TCR\u03b3\u03b4 T-large granular lymphocyte leukemia. Blood 139, 3058\u20133072 (2022).","journal-title":"Blood"},{"key":"3499_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s11899-018-0460-z","volume":"13","author":"W Lone","year":"2018","unstructured":"Lone, W., Alkhiniji, A., Manikkam Umakanthan, J. & Iqbal, J. Molecular insights into pathogenesis of peripheral T cell lymphoma: a review. Curr. Hematol. Malig. Rep. 13, 318\u2013328 (2018).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"3499_CR26","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nrc2251","volume":"7","author":"L Antoni","year":"2007","unstructured":"Antoni, L., Sodha, N., Collins, I. & Garrett, M. D. CHK2 kinase: cancer susceptibility and cancer therapy \u2013 two sides of the same coin? Nat. Rev. Cancer 7, 925\u2013936 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"3499_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/ncb2507","volume":"14","author":"X Gan","year":"2012","unstructured":"Gan, X. et al. PRR5L degradation promotes mTORC2-mediated PKC-\u03b4 phosphorylation and cell migration downstream of G\u03b112. Nat. Cell Biol. 14, 686\u2013696 (2012).","journal-title":"Nat. Cell Biol."},{"key":"3499_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.17.00019","volume":"2","author":"A Greenplate","year":"2018","unstructured":"Greenplate, A. et al. Genomic profiling of T-Cell neoplasms reveals frequent JAK1 and JAK3 mutations with clonal evasion from targeted therapies. JCO Precis. Oncol. 2, 1\u201316 (2018).","journal-title":"JCO Precis. Oncol."},{"key":"3499_CR29","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3390\/cancers11121833","volume":"11","author":"L Wahnschaffe","year":"2019","unstructured":"Wahnschaffe, L. et al. JAK\/STAT-activating genomic alterations are a hallmark of T-PLL. Cancers 11, 1833 (2019).","journal-title":"Cancers"},{"key":"3499_CR30","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio, R. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720\u20131748 (2022).","journal-title":"Leukemia"},{"key":"3499_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.70","volume":"4","author":"Y Sandberg","year":"2014","unstructured":"Sandberg, Y. et al. Lack of common TCRA and TCRB clonotypes in CD8(+)\/TCR\u03b1\u03b2(+) T-cell large granular lymphocyte leukemia: a review on the role of antigenic selection in the immunopathogenesis of CD8(+) T-LGL. Blood Cancer J. 4, e172 (2014).","journal-title":"Blood Cancer J."},{"key":"3499_CR32","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1182\/blood.2023021790","volume":"144","author":"T Marchand","year":"2024","unstructured":"Marchand, T., Lamy, T. & Loughran, T. P. A modern view of LGL leukemia. Blood 144, 1910\u20131923 (2024).","journal-title":"Blood"},{"key":"3499_CR33","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s43018-024-00763-8","volume":"5","author":"M Rade","year":"2024","unstructured":"Rade, M. et al. Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma. Nat. Cancer 5, 1318\u20131333 (2024).","journal-title":"Nat. Cancer"},{"key":"3499_CR34","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1182\/blood-2023-182298","volume":"142","author":"R Montes de Oca","year":"2023","unstructured":"Montes de Oca, R. et al. Biomarker correlates of response to ciltacabtagene autoleucel in patients with relapsed or refractory multiple myeloma from CARTITUDE-1, a phase 1b\/2 open-label study, at the ~3 year follow-up. Blood 142, 2099 (2023).","journal-title":"Blood"},{"key":"3499_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02688-6","volume":"9","author":"A Schrader","year":"2018","unstructured":"Schrader, A. et al. Actionable perturbations of damage responses by TCL1\/ATM and epigenetic lesions form the basis of T-PLL. Nat. Commun. 9, 697 (2018).","journal-title":"Nat. Commun."},{"key":"3499_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-022-05692-z","volume":"615","author":"N Jain","year":"2023","unstructured":"Jain, N. et al. TET2 guards against unchecked BATF3-induced CAR T cell expansion. Nature 615, 315\u2013322 (2023).","journal-title":"Nature"},{"key":"3499_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","volume":"558","author":"JA Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558, 307\u2013312 (2018).","journal-title":"Nature"},{"key":"3499_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4049\/jimmunol.1700559","volume":"200","author":"SA Carty","year":"2018","unstructured":"Carty, S. A. et al. The loss of TET2 promotes CD8+ T cell memory differentiation. J. Immunol. 200, 82\u201391 (2018).","journal-title":"J. Immunol."},{"key":"3499_CR39","doi-asserted-by":"publisher","first-page":"a026518","DOI":"10.1101\/cshperspect.a026518","volume":"7","author":"RL Bowman","year":"2017","unstructured":"Bowman, R. L. & Levine, R. L. TET2 in normal and malignant Hematopoiesis. Cold Spring Harb. Perspect. Med. 7, a026518 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"3499_CR40","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1182\/blood.2019003348","volume":"136","author":"S Oberbeck","year":"2020","unstructured":"Oberbeck, S. et al. Non-canonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling. Blood 136, 2786\u20132802 (2020).","journal-title":"Blood"},{"key":"3499_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","volume":"21","author":"RC Larson","year":"2021","unstructured":"Larson, R. C. & Maus, M. V. Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat. Rev. Cancer 21, 145\u2013161 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"3499_CR42","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1182\/blood.2022017094","volume":"141","author":"MK Samur","year":"2023","unstructured":"Samur, M. K. et al. High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma. Blood 141, 1724\u20131736 (2023).","journal-title":"Blood"},{"key":"3499_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07196-2","volume":"12","author":"I Vicenti","year":"2022","unstructured":"Vicenti, I. et al. External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy. Sci. Rep. 12, 3291 (2022).","journal-title":"Sci. Rep."},{"key":"3499_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ymeth.2021.05.006","volume":"201","author":"W van Snippenberg","year":"2022","unstructured":"van Snippenberg, W. et al. Triplex digital PCR assays for the quantification of intact proviral HIV-1 DNA. Methods 201, 41\u201348 (2022).","journal-title":"Methods"},{"key":"3499_CR45","unstructured":"Schecter, J. M. & Fan, X. BCMA-targeted CAR-T cell therapy for multiple myeloma. Worldwide patent WO2022116086A1 (2022)."},{"key":"3499_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03224-8","volume":"25","author":"D Neavin","year":"2024","unstructured":"Neavin, D. et al. Demuxafy: improvement in droplet assignment by integrating multiple single-cell demultiplexing and doublet detection methods. Genome Biol. 25, 94 (2024).","journal-title":"Genome Biol."},{"key":"3499_CR47","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"P-L Germain","year":"2021","unstructured":"Germain, P.-L., Lun, A., Garcia Meixide, C., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res. 10, 979 (2021).","journal-title":"F1000Res."},{"key":"3499_CR48","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/bioinformatics\/btz698","volume":"36","author":"AS Bais","year":"2020","unstructured":"Bais, A. S. & Kostka, D. Scds: computational annotation of doublets in single-cell RNA sequencing data. Bioinformatics 36, 1150\u20131158 (2020).","journal-title":"Bioinformatics"},{"key":"3499_CR49","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"3499_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Res. 9, 47 (2020).","journal-title":"F1000Res."},{"key":"3499_CR51","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e21 (2019).","journal-title":"Cell"},{"key":"3499_CR52","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1093\/bioinformatics\/btac141","volume":"38","author":"M Andreatta","year":"2022","unstructured":"Andreatta, M., Berenstein, A. J. & Carmona, S. J. ScGate: marker-based purification of cell types from heterogeneous single-cell RNA-seq datasets. Bioinformatics 38, 2642\u20132644 (2022).","journal-title":"Bioinformatics"},{"key":"3499_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23324-4","volume":"12","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat. Commun. 12, 2965 (2021).","journal-title":"Nat. Commun."},{"key":"3499_CR54","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. & Carmona, S. J. UCell: robust and scalable single-cell gene signature scoring. Comput. Struct. Biotechnol. J. 19, 3796\u20133798 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"3499_CR55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.12688\/f1000research.22969.2","volume":"9","author":"R Fu","year":"2020","unstructured":"Fu, R. et al. Clustifyr: an R package for automated single-cell RNA sequencing cluster classification. F1000Res. 9, 223 (2020).","journal-title":"F1000Res."},{"key":"3499_CR56","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","volume":"29","author":"Y Chu","year":"2023","unstructured":"Chu, Y. et al. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat. Med. 29, 1550\u20131562 (2023).","journal-title":"Nat. Med."},{"key":"3499_CR57","doi-asserted-by":"publisher","first-page":"btad626","DOI":"10.1093\/bioinformatics\/btad626","volume":"39","author":"L Larsson","year":"2023","unstructured":"Larsson, L., Franz\u00e9n, L., St\u00e5hl, P. L. & Lundeberg, J. Semla: a versatile toolkit for spatially resolved transcriptomics analysis and visualization. Bioinformatics 39, btad626 (2023).","journal-title":"Bioinformatics"},{"key":"3499_CR58","doi-asserted-by":"publisher","first-page":"e0163962","DOI":"10.1371\/journal.pone.0163962","volume":"11","author":"W Shen","year":"2016","unstructured":"Shen, W., Le, S., Li, Y. & Hu, F. SeqKit: a cross-platform and ultrafast toolkit for FASTA\/Q file manipulation. PLoS ONE 11, e0163962 (2016).","journal-title":"PLoS ONE"},{"key":"3499_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqae031","volume":"6","author":"F Hanssen","year":"2024","unstructured":"Hanssen, F. et al. Scalable and efficient DNA sequencing analysis on different compute infrastructures aiding variant discovery. NAR Genom. Bioinform. 6, lqae031 (2024).","journal-title":"NAR Genom. Bioinform."},{"key":"3499_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00791-w","volume":"12","author":"DC Koboldt","year":"2020","unstructured":"Koboldt, D. C. Best practices for variant calling in clinical sequencing. Genome Med. 12, 91 (2020).","journal-title":"Genome Med."},{"key":"3499_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0425-1","volume":"9","author":"M Callari","year":"2017","unstructured":"Callari, M. et al. Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers. Genome Med. 9, 35 (2017).","journal-title":"Genome Med."},{"key":"3499_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"3499_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/1755-0998.12549","volume":"17","author":"BJ Knaus","year":"2017","unstructured":"Knaus, B. J. & Gr\u00fcnwald, N. J. Vcfr: a package to manipulate and visualize variant call format data in R. Mol. Ecol. Resour. 17, 44\u201353 (2017).","journal-title":"Mol. Ecol. Resour."},{"key":"3499_CR64","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s42003-021-01938-0","volume":"4","author":"EH Rustad","year":"2021","unstructured":"Rustad, E. H. et al. Mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies. Commun. Biol. 4, 424 (2021).","journal-title":"Commun. Biol."},{"key":"3499_CR65","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","volume":"32","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32, 1220\u20131222 (2016).","journal-title":"Bioinformatics"},{"key":"3499_CR66","doi-asserted-by":"publisher","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","volume":"28","author":"T Rausch","year":"2012","unstructured":"Rausch, T. et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 28, i333\u2013i339 (2012).","journal-title":"Bioinformatics"},{"key":"3499_CR67","doi-asserted-by":"publisher","unstructured":"Braun, T. et al. Multi-omic single-cell dissection of leukemic T-cell lymphoma following CAR T-cell therapy. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14251446 (2023).","DOI":"10.5281\/zenodo.14251446"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03499-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03499-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03499-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T18:02:29Z","timestamp":1744826549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03499-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3499"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03499-9","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"20 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.M. gave advisory boards and received honoraria and research support from Amgen, BMS, Celgene, Gilead, Janssen, Stemline, Springworks, Sanofi and Takeda. U.H. received consultant and\/or speaker fees from Bristol-Myers Squibb, Gilead, Janssen, Miltenyi Biotec and Novartis. C.S. gave advisory boards and received honoraria from Amgen, Abbvie, Bristol-Myers Squibb, Janssen, Novartis, Oncopeptides, Pfizer, Roche, Sanofi, Stemline Menarini and Takeda, and received research support from Janssen and Takeda. U.K. received consultant and\/or speaker fees from AstraZeneca, Affimed, Glycostem, GammaDelta, Zelluna, CGT manufacturing: Miltenyi Biotec and Novartis Pharma GmbH, Bristol-Myers Squibb GmbH & Co. M. Herling gave advisory boards and received honoraria from Abbvie, Beigene, Jazz, Janssen, Stemline Menarini and Takeda, and received research support from EDO-Mundipharma, Janpix, Novartis and Roche. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}